Finance

Lists
CAH:NYSE
Cardinal Health, Inc
$ 237.57
-0.58%
(-1.39) 1D
$ 237.57
0.00% (0.00)
After hours
Closed: 10-р сарын 9, 16:00:03 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAH...
Open
$ 237.79
High
$ 239.81
Low
$ 236.37
Mkt. cap
55.01 тэрбум
Avg. vol.
1.73 сая
Volume
1.03 сая
Dividend
0.87%
Quarterly dividend
$ 0.52
Ex-dividend date
2026 оны 10-р сарын 1
P/E ratio
32.85
52-wk high
$ 258.30
52-wk low
$ 151.87
EPS
$ 7.23
Beta
0.50
Shares outstanding
231.56 сая
No. of employees
61 мян
Open
$ 237.79
High
$ 239.81
Low
$ 236.37
Mkt. cap
55.01 тэрбум
Avg. vol.
1.73 сая
Volume
1.03 сая
Dividend
0.87%
Quarterly dividend
$ 0.52
Ex-dividend date
2026 оны 10-р сарын 1
P/E ratio
32.85
52-wk high
$ 258.30
52-wk low
$ 151.87
EPS
$ 7.23
Beta
0.50
Shares outstanding
231.56 сая
No. of employees
61 мян
News stories
From web sources and news partners
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health, Inc
CEOJason Hollar
Employees61.3 мян
Founded1971
HeadquartersDublin, Охайо, Америкийн Нэгдсэн Улс
SectorHealth care provider
Analyst ratings
Based on 14 analysts giving stock ratings to CAH in the past 3 months
Strong buy
Buy
12
Hold
2
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CAH in the last 3 months.
Highest
Current $ 237.57
$ 292.00 (+22.91%)
Average
$ 270.00 (+13.65%)
Lowest
$ 250.00 (+5.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
$ 276.00
+16.2%
10/06/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$ 277.00
+16.6%
09/09/2026
Glen Santangelo
Barclays
Buy
Reiterated
$ 275.00
+15.8%
08/18/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
$ 260.00
+9.4%
08/17/2026
George Hill
Deutsche Bank
Hold
Maintained
$ 261.00
+9.9%
08/13/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
$ 250.00
+5.2%
08/13/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
$ 280.00
+17.9%
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$ 270.00
+13.7%
08/12/2026
Erin Wright
Morgan Stanley
Buy
Maintained
$ 255.00
+7.3%
08/12/2026
Daniel Grosslight
Citi
Buy
Maintained
$ 280.00
+17.9%
08/12/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$ 277.00
+16.6%
08/12/2026
Michael Cherny
Leerink Partners
Buy
Maintained
$ 292.00
+22.9%
08/11/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/11/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
$ 260.00
+9.4%
07/20/2026
Kevin Caliendo
UBS
Buy
Reiterated
$ 274.00
+15.3%
07/20/2026
Unknown Analyst
William O'Neil
Buy
Initiated
-
-
06/12/2026
Unknown Analyst
Argus Research
Buy
Maintained
$ 248.00
+4.4%
05/05/2026
Steven Silver
Argus Research
Buy
Maintained
$ 248.00
+4.4%
05/05/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
$ 248.00
+4.4%
05/01/2026
Max Smock
William Blair
Buy
Initiated
-
-
04/28/2026
Last report
2026 оны 8-р сарын 11
Fiscal period
Q4 2026
$ 2.60 / $ 2.42
+7.41%beat
Revenue / Est. (USD)
63.67 тэрбум / 65.11 тэрбум
-2.20%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
64.01 тэрбум
65.63 тэрбум
60.94 тэрбум
63.67 тэрбум
Cost of goods sold
61.69 тэрбум
63.23 тэрбум
58.44 тэрбум
61.11 тэрбум
Cost of revenue
61.69 тэрбум
63.23 тэрбум
58.44 тэрбум
61.11 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.46 тэрбум
1.50 тэрбум
1.54 тэрбум
1.62 тэрбум
Operating expense
1.55 тэрбум
1.59 тэрбум
1.64 тэрбум
1.71 тэрбум
Total operating expenses
63.24 тэрбум
64.82 тэрбум
60.08 тэрбум
62.82 тэрбум
Operating income
771.00 сая
809.00 сая
861.00 сая
847.00 сая
Other non operating income
10.00 сая
11.00 сая
-16.00 сая
30.00 сая
EBT including unusual items
598.00 сая
630.00 сая
392.00 сая
554.00 сая
EBT excluding unusual items
701.00 сая
732.00 сая
744.00 сая
794.00 сая
Income tax expense
144.00 сая
159.00 сая
12.00 сая
154.00 сая
Effective tax rate
24.08%
25.24%
3.06%
27.80%
Other operating expenses
-
-
-
-
Net income
450.00 сая
467.00 сая
399.00 сая
398.00 сая
Net profit margin
0.70%
0.71%
0.65%
0.62%
Earnings per share
2.55
2.63
3.17
2.60
Interest and investment income
-
-
-
-
Interest expense
-80.00 сая
-88.00 сая
-101.00 сая
-103.00 сая
Net interest expenses
-80.00 сая
-88.00 сая
-101.00 сая
-103.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.00 тэрбум
1.04 тэрбум
1.11 тэрбум
1.09 тэрбум
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс